Cargando…

Evolution of Neutralization Response in HIV-1 Subtype C-Infected Individuals Exhibiting Broad Cross-Clade Neutralization of HIV-1 Strains

Strain-specific neutralizing antibodies develop in all human immunodeficiency virus type 1 (HIV-1)-infected individuals. However, only 10–30% of infected individuals produce broadly neutralizing antibodies (bNAbs). Identification and characterization of these bNAbs and understanding their evolution...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheedarla, Narayanaiah, Hemalatha, Babu, Anangi, Brahmaiah, Muthuramalingam, Kannan, Selvachithiram, Murugesan, Sathyamurthi, Pattabiraman, Kailasam, Nandagopal, Varadarajan, Raghavan, Swaminathan, Soumya, Tripathy, Srikanth Prasad, Vaniambadi, S. Kalyanaraman, Vadakkupattu, D. Ramanathan, Hanna, Luke Elizabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890096/ https://www.ncbi.nlm.nih.gov/pubmed/29662494 http://dx.doi.org/10.3389/fimmu.2018.00618

Ejemplares similares

Broad and potent cross clade neutralizing antibodies with multiple specificities in the plasma of HIV-1 subtype C infected individuals
por: Cheedarla, Narayanaiah, et al.
Publicado: (2017)

Cross Type Neutralizing Antibodies Detected in a Unique HIV-2 Infected Individual From India
por: Vidyavijayan, K. K., et al.
Publicado: (2018)

Pooled Testing Strategies for SARS-CoV-2 diagnosis: A comprehensive review
por: Daniel, Evangeline Ann, et al.
Publicado: (2021)

Structure-guided changes at the V2 apex of HIV-1 clade C trimer enhance elicitation of autologous neutralizing and broad V1V2-scaffold antibodies
por: Sahoo, Anusmita, et al.
Publicado: (2022)

Inducing Cross-Clade Neutralizing Antibodies against HIV-1 by Immunofocusing
por: Humbert, Michael, et al.
Publicado: (2008)

COVID-19 vaccine induced poor neutralization titers for SARS-CoV-2 omicron variants in maternal and cord blood
por: Govindaraj, Sakthivel, et al.
Publicado: (2023)

An Efficiently Cleaved HIV-1 Clade C Env Selectively Binds to Neutralizing Antibodies
por: Boliar, Saikat, et al.
Publicado: (2015)

Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection
por: Wagh, Kshitij, et al.
Publicado: (2016)

Neutralizing Activity of Broadly Neutralizing Anti-HIV-1 Antibodies against Clade B Clinical Isolates Produced in Peripheral Blood Mononuclear Cells
por: Cohen, Yehuda Z., et al.
Publicado: (2018)

Nanobodies that Neutralize HIV
por: Weiss, Robin A., et al.
Publicado: (2019)

Neutralizing Antibody Responses and Evolution of the Viral Envelope in the Course of HIV-1 Korean Clade B Infection
por: Shin, Bo Gyeong, et al.
Publicado: (2011)

Elicitation of potent serum neutralizing antibody responses in rabbits by immunization with an HIV-1 clade C trimeric Env derived from an Indian elite neutralizer
por: Kumar, Rajesh, et al.
Publicado: (2021)

Neutralization Sensitivity and Evolution of Virus in a Chronic HIV-1 Clade B Infected Patient with Neutralizing Activity against Membrane-Proximal External Region
por: Tang, Wenqi, et al.
Publicado: (2023)

P04-03. Cross-clade neutralization analysis of plasmas from clade B, C and CRF01_AE HIV-infected donors
por: Binley, J, et al.
Publicado: (2009)

Identification of Non-HIV Immunogens That Bind to Germline b12 Predecessors and Prime for Elicitation of Cross-clade Neutralizing HIV-1 Antibodies
por: Yang, Zheng, et al.
Publicado: (2015)

Focusing the immune response on the V3 loop of HIV-1 gp120 induces cross-clade neutralizing
por: Zolla-Pazner, Susan, et al.
Publicado: (2006)

Cross-clade neutralization potential of the plasma of antiretroviral naïve HIV-1 infected children from north India
por: Sankaran, Prakash Somi, et al.
Publicado: (2012)

Immunization with HIV-1 envelope T20-encoding DNA vaccines elicits cross-clade neutralizing antibody responses
por: Stenler, S., et al.
Publicado: (2017)

Estimating the Stoichiometry of HIV Neutralization
por: Magnus, Carsten, et al.
Publicado: (2010)

Neutralization tiers of HIV-1
por: Montefiori, David C., et al.
Publicado: (2018)

Antibodies from Rabbits Immunized with HIV-1 Clade B SOSIP Trimers Can Neutralize Multiple Clade B Viruses by Destabilizing the Envelope Glycoprotein
por: van Haaren, M. M., et al.
Publicado: (2021)

Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies
por: McCoy, Laura E., et al.
Publicado: (2015)

Systemic Inflammation and the Increased Risk of Inflamm-Aging and Age-Associated Diseases in People Living With HIV on Long Term Suppressive Antiretroviral Therapy
por: Babu, Hemalatha, et al.
Publicado: (2019)

HIV-1 clade C escapes broadly neutralizing autologous antibodies with N332 glycan specificity by distinct mechanisms
por: Deshpande, Suprit, et al.
Publicado: (2016)

Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
por: Landais, Elise, et al.
Publicado: (2018)

Broadly Neutralizing Antibodies for HIV Eradication
por: Stephenson, Kathryn E., et al.
Publicado: (2016)

Identification of a clade A HIV envelope immunogen from Protocol G that elicits neutralizing antibodies to tier 2 viruses
por: Hoffenberg, S, et al.
Publicado: (2012)

Complementary antibody lineages achieve neutralization breadth in an HIV-1 infected elite neutralizer
por: van Schooten, Jelle, et al.
Publicado: (2022)

Broad and ultra-potent cross-clade neutralization of HIV-1 by a vaccine-induced CD4 binding site bovine antibody
por: Heydarchi, Behnaz, et al.
Publicado: (2022)

Neutralizing antibodies to HIV-1 induced by immunization
por: McCoy, Laura E., et al.
Publicado: (2013)

Neutralization-Enhancing RF Antibodies for HIV Vaccines
por: Suslov, Konstantin V.
Publicado: (2014)

HIV vaccine development and broadly neutralizing antibodies
por: Greenspan, Neil S., et al.
Publicado: (2015)

The expanding array of HIV broadly neutralizing antibodies
por: McCoy, Laura E.
Publicado: (2018)

Broadly Neutralizing Antibodies for HIV-1 Prevention
por: Walsh, Stephen R., et al.
Publicado: (2021)

Broadly neutralizing monoclonal antibodies for HIV prevention
por: Miner, Maurine D., et al.
Publicado: (2021)

Impact of COVID-19 Vaccination on Pregnant Women
por: Chaubey, Ishaan, et al.
Publicado: (2023)

S021-06 OA. Potent and broad neutralizing antibodies from HIV-1 non-clade B infected donor reveal a new HIV-1 vaccine target
por: Phogat, SK, et al.
Publicado: (2009)

Distinct conformational states of HIV-1 gp41 are recognized by neutralizing and non-neutralizing antibodies
por: Frey, Gary, et al.
Publicado: (2010)

The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies
por: Sok, Devin, et al.
Publicado: (2013)

Computational Prediction of Broadly Neutralizing HIV-1 Antibody Epitopes from Neutralization Activity Data
por: Ferguson, Andrew L., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_r5fd6d7h7q19c8kedvd59ivbrc